Asset Management One’s Ultragenyx Pharmaceutical RARE Stock Holding History

Asset Management One’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,314	Closed	-$551K	–	1033
2022 Q3	$551K	Hold	13,314	–	–	﹤0.01%	877
2022 Q2	$794K	Hold	13,314	–	–	﹤0.01%	859
2022 Q1	$966K	Hold	13,314	–	–	﹤0.01%	857
2021 Q4	$1.1M	Hold	13,314	–	–	﹤0.01%	860
2021 Q3	$1.2M	Hold	13,314	–	–	﹤0.01%	842
2021 Q2	$1.27M	Hold	13,314	–	–	﹤0.01%	844
2021 Q1	$1.51M	Hold	13,314	–	–	0.01%	823
2020 Q4	$1.96M	Hold	13,314	–	–	0.01%	786
2020 Q3	$1.09M	Sell	13,314 -4,873	-27%	-$404K	0.01%	828
2020 Q2	$1.42M	Hold	18,187	–	–	0.01%	800
2020 Q1	$808K	Hold	18,187	–	–	﹤0.01%	834
2019 Q4	$777K	Hold	18,187	–	–	﹤0.01%	896
2019 Q3	$778K	Hold	18,187	–	–	﹤0.01%	893
2019 Q2	$1.16M	Sell	18,187 -18,449	-50%	-$1.17M	0.01%	871
2019 Q1	$2.54M	Buy	36,636 +5,706	+18%	+$326K	0.01%	750
2018 Q4	$1.3M	Sell	30,930 -421	-1%	-$23K	﹤0.01%	837
2018 Q3	$2.5M	Sell	31,351 -6,982	-18%	-$568K	0.01%	796
2018 Q2	$2.92M	Sell	38,333 -10,206	-21%	-$659K	0.01%	800
2018 Q1	$2.48M	Hold	48,539	–	–	0.01%	801
2017 Q4	$2.28M	Hold	48,539	–	–	0.01%	832
2017 Q3	$2.62M	Hold	48,539	–	–	0.01%	814
2017 Q2	$3M	Buy	48,539 +7,320	+18%	+$441K	0.01%	760
2017 Q1	$2.77M	Buy	41,219 +17,600	+75%	+$1.34M	0.01%	760
2016 Q4	$1.66M	Buy	23,619 +2,602	+12%	+$185K	﹤0.01%	784
2016 Q3	$1.44M	Buy	21,017 +17,435	+487%	+$1.11M	0.02%	722
2016 Q2	$177K	Buy	+3,582	New	+$232K	﹤0.01%	1213

Other funds holding RARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Asset Management One's RARE Position: Q4 2022 in Review

Asset Management One sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2022, closing a stake of 13,314 shares — an estimated $551K sold.

Asset Management One first reported a position in RARE in Q2 2016 and held it in 26 quarters. The position peaked at $3M in Q2 2017. 228 funds tracked by Wall St. Rank hold RARE as of Q4 2022.

Asset Management One reported no remaining Ultragenyx Pharmaceutical position as of Q4 2022 after selling out during the quarter.
Asset Management One sold 13,314 Ultragenyx Pharmaceutical shares in Q4 2022, an estimated $551K.
Asset Management One first reported a position in Ultragenyx Pharmaceutical in Q2 2016 and held it in 26 quarters.
Asset Management One's Ultragenyx Pharmaceutical position peaked at $3M in Q2 2017.
228 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2022.

Based on Asset Management One's 13F filing for Q4 2022, filed 6 Feb 2023.